Bleakley Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.5M | Buy |
32,739
+5,130
| +19% | +$4M | 0.65% | 36 |
|
|
2025
Q1 | $22.8M | Buy |
27,609
+1,568
| +6% | +$1.3M | 0.73% | 28 |
|
|
2024
Q4 | $20.1M | Buy |
26,041
+708
| +3% | +$547K | 0.61% | 31 |
|
|
2024
Q3 | $22.4M | Sell |
25,333
-22,596
| -47% | -$20M | 0.68% | 26 |
|
|
2024
Q2 | $43.4M | Sell |
47,929
-276
| -0.6% | -$250K | 1.25% | 15 |
|
|
2024
Q1 | $37.5M | Buy |
48,205
+2,041
| +4% | +$1.59M | 1.09% | 16 |
|
|
2023
Q4 | $26.9M | Buy |
46,164
+119
| +0.3% | +$69.4K | 0.86% | 18 |
|
|
2023
Q3 | $24.7M | Sell |
46,045
-7,025
| -13% | -$3.77M | 0.87% | 18 |
|
|
2023
Q2 | $24.9M | Buy |
53,070
+1,165
| +2% | +$546K | 0.78% | 20 |
|
|
2023
Q1 | $17.8M | Buy |
51,905
+6,474
| +14% | +$2.22M | 0.6% | 29 |
|
|
2022
Q4 | $16.6M | Buy |
+45,431
| New | +$16.6M | 0.59% | 30 |
|